Time course of central retinal thickness (CRT) in all eyes. by Yasuyuki Sotani (20114144)

“…<p>Mean CRT (μm ± standard deviation) significantly decreased from 504.7 ± 118.2 μm preoperatively to 302.5 ± 60.5 at 1 month, 307.5 ± 64.4 at 3 months, 286.8 ± 49.0 at 6 months, 305.3 ± 79.5 at 12 months, 288.8 ± 79.1 at 24 months, and 295.2 ± 87.4 at 36 months (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”

Annual treatment frequencies in all eyes. by Yasuyuki Sotani (20114144)

“…<p>The number of anti-VEGF treatments, STTA, MA-PC, PPV, and total treatments (mean ± SD) significantly decreased from 2.6 ± 1.6, 0.3 ± 0.8, 0.6 ± 0.8, 0.1 ± 0.3, and 3.7 ± 1.7 preoperatively to 0.8 ± 1.9, 0.0 ± 0.2, 0.3 ± 1.0, 0.0, and 1.2 ± 2.2; at year 2 to 0.7 ± 2.0, 0.1 ± 0.6, 0.0 ± 0.2, 0.0 ± 0.2, and 1.0 ± 2.1; and at year 3 to 0.9 ± 2.2, 0.0, 0.2 ± 1.0, 0.0 ± 0.2, and 1.1 ± 3.1 (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”

Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…CRT in the recurrence group significantly decreased from 546.1 ± 117.0 μm preoperatively to 317.1 ± 46.9, 317.8 ± 55.6, 290.8 ± 33.5, 342.9 ± 82.2, 333.0 ± 84.2, and 349.8 ± 76.9 μm at 1, 3, 6, 12, 24, and 36 months postoperatively, respectively (Kruskal-Wallis test, p < 0.001). …”

Time course of central retinal thickness (CRT) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…These values significantly decreased in the first postoperative year to 2.3 ± 2.6, 0.1 ± 0.3, 0.8 ± 1.6, 0, and 3.1 ± 2.8; in the second year to 2.1 ± 2.8, 0.4 ± 1.0, 0.0, 0.1 ± 0.3, and 2.6 ± 2.8; and in the third year to 2.0 ± 2.2, 0, 0.6 ± 1.7, 0.1 ± 0.3, and 2.8 ± 3.5 (Kruskal–Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g007" target="_blank">Fig 7</a>). …”

Conceptual diagram of survival curve and loss of life expectancy. by Hiroaki Saito (24514)

A representative ultrasound axis image. by Eun-Seon Yang (19751340)

“…SBP showed an increasing trend, but this was not statistically significant (<i>p</i> = 0.108). Interestingly, we observed significant decreases in arterial stiffness and PWV in POST_VM when comparing with PRE_VM (<i>p</i><0.001 and <i>p</i><0.001, respectively). …”

Thioflavin-T (ThT) fluorescence analysis of amyloid fibril formation in wild-type and p.R163C mutant αB-crystallin under thermochemical stress. by Aref Baharvand (21713886)

Differences among the classes of CAMs. by Daniel P. Bradley (10306893)

“…<div><p>Hepatitis B virus (HBV) ribonuclease H (RNaseH) inhibitors are a potent class of antivirals that prevent degradation of the viral pregenomic RNA during reverse transcription and block formation of mature HBV DNAs. …”

A representative participant performing a Valsalva maneuver while checking the real-time respiratory pressure indicator. by Eun-Seon Yang (19751340)

The structural equation model showed the direct and indirect effects of plant factors and soil factors on plant species diversity and plant functional diversity. (a) Structural equ... by Xuemei Xiang (20756894)

Raw data. by Saeedeh Abbasi (9423189)

“…However, both groups exhibited a significant decrease in CCI during prolonged standing (time *  condition: p =  0.003). …”

Data. by Saeedeh Abbasi (9423189)

“…However, both groups exhibited a significant decrease in CCI during prolonged standing (time *  condition: p =  0.003). …”

Fig 11 - by Naveed Arshad (19712985)

Fig 9 - by Naveed Arshad (19712985)

Fig 10 - by Naveed Arshad (19712985)

Graph of the risk of bias for the included randomized controlled trials (A); Summary of the risk of bias for the included randomized controlled trials (B). by Zhuoyang Xia (21354186)

Stereotactic injection of AAV-miR-129-5p attenuated microglia activation in depressed mice. by Qiaozhen Qin (13159201)

Stereotactic injection of AAV-miR-129-5p suppressed astrocyte activation in depressed mice. by Qiaozhen Qin (13159201)

Overexpression of miR-129-5p alleviated depression-like behaviors by increasing ATP content. by Qiaozhen Qin (13159201)

CONSORT of participants with OPV status. by Zahid Hasan Khan (6281396)

“…<div><p>Most vaccinations in the immunization schedule need two or more doses to elicit a protective immune response. …”